Cargando…

1595. Comparative In Vitro Activity of Imipenem–Relebactam Against Drug-Resistant Gram-Negative Isolates from Pediatric Patients

BACKGROUND: Drug resistance in Gram-negative bacteria is of particular concern in children. Relebactam, a novel diazabicyclooctane inhibitor, coupled with imipenem has broad-spectrum activity against β-lactamase producing organisms. Here, we compare the in vitro activity of imipenem-relebactam to 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Dithi, Harrison, Christopher J, Pence, Morgan, Selvarangan, Rangaraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808878/
http://dx.doi.org/10.1093/ofid/ofz360.1459